Blood Pressure in Acute Stroke: 185/110, 180/105, and When Not to Treat

Few numbers cause as much bedside confusion as blood pressure in acute stroke. One patient’s 190/100 triggers an urgent call and a nicardipine drip; the patient in the next bed sits at the same pressure and the team deliberately leaves it alone. Both are correct. The difference isn’t the number — it’s which stroke, and what treatment the patient received.

There are really three separate rules, and knowing which one applies to the patient in front of you is the entire skill.

Rule 1: before thrombolytics — below 185/110

To receive alteplase or tenecteplase, a patient’s blood pressure must be below 185/110 mmHg. Above that, the bleeding risk from thrombolysis climbs, so the pressure has to come down before the drug goes in.

This is the number that runs on the clock. The team is racing a treatment window, and blood pressure is often the last barrier between the patient and the drug. Expect labetalol pushes or a nicardipine infusion started urgently, and expect to be asked for a pressure every few minutes.

Rule 2: after thrombolytics — below 180/105 for 24 hours

Once the drug is in, the target changes and stays changed. Keep the blood pressure below 180/105 mmHg for at least 24 hours.

This is the single most important number on a post-thrombolytic patient, because it is the one that prevents symptomatic intracranial hemorrhage. It applies whether the patient received tenecteplase as a single bolus or alteplase as a bolus plus a one-hour infusion — the drug changed, the monitoring did not.

The monitoring schedule is built around catching a breach early: commonly every 15 minutes for 2 hours, every 30 minutes for 6 hours, then hourly to 24 hours — though you should follow your facility’s protocol. A rising pressure paired with a new headache, nausea, or any neurologic decline is a hemorrhage until proven otherwise.

Rule 3: ischemic stroke with no thrombolytics — permissive hypertension

This is the rule that feels wrong the first time you work it. A patient with an acute ischemic stroke who did not receive thrombolytics is generally left hypertensive.

The reasoning is perfusion. Around the dead core of an infarct sits the penumbra — tissue that is threatened but still salvageable, kept alive by collateral flow that depends on driving pressure. Lower the blood pressure aggressively and you can extend the infarct into tissue that would have survived.

So the threshold for treating is much higher — generally reserved for pressures above roughly 220/120 mmHg, and even then the goal is a gradual reduction (on the order of 15% in the first 24 hours), not normalization.

Two things override permissive hypertension, and they’re worth knowing because they’re the reason a patient gets treated anyway:

• A competing emergency that itself demands lower pressure — aortic dissection, acute coronary syndrome, acute heart failure, or hypertensive encephalopathy.
• The patient becomes a candidate for intervention, at which point Rule 1 takes over.

Hemorrhagic stroke is a different rule entirely

Everything above concerns ischemic stroke. In intracerebral hemorrhage, there’s no penumbra to protect with driving pressure — high pressure drives ongoing bleeding and hematoma expansion. So the direction of care reverses: for patients presenting with a systolic in the range of roughly 150–220, acute lowering toward a systolic around 140 mmHg is generally reasonable.

The caution here is the mirror image of the ischemic one: avoid overshooting downward. Very aggressive reduction hasn’t shown benefit and may cause harm, so the goal is a controlled landing, not the lowest number you can achieve.

What this looks like on your shift

Situation	Target	The risk you’re managing
Before thrombolytics	< 185/110	Bleeding risk from the drug
After thrombolytics, 24 h	< 180/105	Symptomatic hemorrhage
Ischemic, no thrombolytics	Permissive; treat above ~220/120	Extending the infarct
Intracerebral hemorrhage	Systolic toward ~140	Hematoma expansion

A few practical notes that apply across all four:

• Trend beats snapshot. One reading is noise. Document the trajectory so the next clinician can see where the pressure is heading, not just where it landed.
• Verify before you treat. A cuff that’s too small, an arm above heart level, or a patient mid-cough can manufacture a pressure that triggers an unnecessary intervention. Recheck manually when a reading doesn’t fit the picture.
• Watch the mean, not only the systolic, particularly on a titratable drip where perfusion is the actual concern. If you’re checking the arithmetic, the MAP calculator will do it.
• Titratable beats intermittent when a target has to hold. Nicardipine and clevidipine infusions are easier to keep inside a window than repeated pushes, which is why they show up on post-thrombolytic patients.

The bottom line

The number on the monitor means nothing until you know two things about the patient: clot or bleed, and thrombolytic or not. Those two answers pick the rule, and the rule tells you whether 190/100 is an emergency or exactly where the team wants the patient to be.

Keep going

The drug side of this: TNK vs tPA — what stroke nurses do differently, and the monitoring schedule generator at TNK monitoring schedule. For charting the exam that runs alongside these pressures, see neuro checks: documenting them defensibly.

Sources